Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trinity Biotech (TRIBY) -- Ignore unavailable to you. Want to Upgrade?

To: DMore who wrote (8398)	3/6/1998 3:01:00 AM
From: Greg Jenkins	Read Replies (1) \| Respond to of 14328

Well I want to thank all the contestants for their entries. It appears we have a winner. Remember, the rules were the one that came closest without going over the actual fully diluted earnings per share. Milton appears to be the winner with an entry of .05 per share. Will our offical please verify the winning entry. As soon as the entry has the offical seal of approval, Milton, can fax a copy of your Feb statement for verification purposes and your check will be on the way. Please send me email at GJ5749@aol.com so I may email you my fax number or address. Please advise your address and who check should be made out to. This stock has got to go up soon. I bought big time at $4.05 awhile ago and I want a new video card for my computer. Till next time. Greg J.

To: DMore who wrote (8398)	3/6/1998 8:50:00 AM
From: Hope	Read Replies (1) \| Respond to of 14328

As per Scott, BKF is not comfortable with .15 for the year. Why are you calling for .189? While we would all like to see this, BKF probably has a better feel about these numbers than any of us and it would be better to be realistic and pleasantly surprised than overly optimistic and disappointed. Still long on Triby, Hope

To: DMore who wrote (8398)	3/6/1998 9:28:00 AM
From: Scott H. Davis	Read Replies (2) \| Respond to of 14328

DMore & All: There is the potential for > 30% annual growth in EPS if revenues grow 30% since margins would improve (assuming SG&A expenses stay in line), but you're adding 30% qtrly, not annually. Brendan was not comfortable with the .15 projection for this year, so .189 appears to be really streatching it. But as an example of the margins effect, EQNX is having 14% revenue growth, but >25% EPS growth due to fixed costs being spread over more sales, and good cost controls. It can happen, but we'll need to monitor the sales/expenses ratios to see if TRIBY can acheive the improved margin dynamic. All 4 now, Scott